Side Effects and Safety Measures The potential for Retatrutide provides exciting prospects, yet it's essential to understand its side effect profile, which may include common mild to moderate issues akin to other GLP-1-based medications
Week 12 showed more substantial progress at 8-9% weight loss, with visible changes in body composition becoming apparent
doi: 10.1016/j.cgh.2024.04.038
Approximately 20.9% of patients on the 12 mg dose reported dysesthesia, a condition involving skin sensitivity, tingling, or tenderness to touch
Rachel Brazil looks at the difficulties in making the peptides themselves, and whats coming next Its rare that the public becomes aware of a recently approved drug, but the chances are youve heard of semaglutide, or its tradename Ozempic, one of a growing number of drugs that replicates the action of the natural hormone, glucagon-like peptide-1